kiCAP-AAV-MyoAAV2A
(Plasmid
#224440)
-
PurposeRep/Cap plasmid for the production of MyoAAV 2A, a muscle-tropic AAV capsid in mice.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 224440 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepUC57-Kan
-
Vector typeAAV
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature30°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameAAV9 VP1 modified with 7mer insertion between amino acids 588 and 589
-
Alt nameMyoAAV 2A
-
SpeciesSynthetic
-
Insert Size (bp)2232
-
MutationRGDQTTL insert between amino acids 588 and 589 of AAV9 VP1, S586G, A587P, Q588G
- Promoter p41
Cloning Information
- Cloning method Gibson Cloning
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Insert was cloned via BsiWI (5') and AgeI (3', preserved in cloning) sites
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
kiCAP-AAV-MyoAAV2A was a gift from Pardis Sabeti (Addgene plasmid # 224440 ; http://n2t.net/addgene:224440 ; RRID:Addgene_224440) -
For your References section:
Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species. Tabebordbar M, Lagerborg KA, Stanton A, King EM, Ye S, Tellez L, Krunnfusz A, Tavakoli S, Widrick JJ, Messemer KA, Troiano EC, Moghadaszadeh B, Peacker BL, Leacock KA, Horwitz N, Beggs AH, Wagers AJ, Sabeti PC. Cell. 2021 Sep 16;184(19):4919-4938.e22. doi: 10.1016/j.cell.2021.08.028. Epub 2021 Sep 9. 10.1016/j.cell.2021.08.028 PubMed 34506722